A 33-year-old longevity clinic owner says her biological age is 22. Here are her 2 favorite biohacks.Kayla Barnes-Lentz claims biohacking has reversed her biological age by 11 years, emphasizing the importance of sleep and experimental treatments.
Right to TryRight-to-try laws enable terminally ill patients to access experimental treatments without FDA approval, raising ethical and safety concerns.
FDA Approves Second Alzheimer's Drug That Can Modestly Slow DiseaseFDA approved Kisunla, a new Alzheimer's drug that slows cognitive decline modestly for early-stage patients.
FDA approves a second Alzheimer's drug that can modestly slow diseaseA new Alzheimer's drug approved by U.S. officials can modestly slow the disease, offering a new option for early-stage patients.
FDA Approves Second Alzheimer's Drug That Can Modestly Slow DiseaseFDA approved Kisunla, a new Alzheimer's drug that slows cognitive decline modestly for early-stage patients.
FDA approves a second Alzheimer's drug that can modestly slow diseaseA new Alzheimer's drug approved by U.S. officials can modestly slow the disease, offering a new option for early-stage patients.